(Q34918273)

5 August 2017

1 reference

title

Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir (English)

1 reference

5 August 2017

0 references

1 reference

Stephen K Tyring

1

1 reference

5 August 2017

David Baker

series ordinal

2

1 reference

5 August 2017

Wendy Snowden

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Infectious Diseases

5 August 2017

published in

1 reference

5 August 2017

volume

186 Suppl 1

1 reference

5 August 2017

page(s)

S40-6

1 reference

Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study

5 August 2017

cites work

1 reference

Pharmacokinetics of acyclovir suspension in infants and children

21 January 2018

1 reference

A controlled trial of acyclovir for chickenpox in normal children

21 January 2018

1 reference

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial

21 January 2018

1 reference

Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

21 January 2018

1 reference

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

21 January 2018

1 reference

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

21 January 2018

1 reference

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

21 January 2018

1 reference

Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials

21 January 2018

1 reference

Preclinical development of antiviral drugs

21 January 2018

1 reference

Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).

21 January 2018

1 reference

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

21 January 2018

1 reference

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis S

21 January 2018

1 reference

Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection

21 January 2018

1 reference

Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?

21 January 2018

1 reference

An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus

21 January 2018

1 reference

Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

21 January 2018

1 reference

Foscarnet-resistant herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

Recurrence and resistance patterns of herpes simplex virus following cessation of > or = 6 years of chronic suppression with acyclovir. Acyclovir Study Group

21 January 2018

1 reference

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

21 January 2018

1 reference

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

21 January 2018

1 reference

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey

21 January 2018

1 reference

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342966

1 reference

5 August 2017

1 reference